Entry |
|
Name |
Deleted p16(INK4a) to p16-cell cycle G1/S
|
Definition |
CDKN2A* // (CCND+CDK4/6) -> RB1 // E2F |
Expanded |
1029v1 // ((595,894,896)+(1019,1021)) -> 5925 // (1869,1870,1871) |
Class |
|
Type |
Variant
|
Pathway |
|
Disease |
H00048 | Hepatocellular carcinoma |
|
Gene |
1029 | CDKN2A; cyclin dependent kinase inhibitor 2A |
1019 | CDK4; cyclin dependent kinase 4 |
1021 | CDK6; cyclin dependent kinase 6 |
5925 | RB1; RB transcriptional corepressor 1 |
1869 | E2F1; E2F transcription factor 1 |
1870 | E2F2; E2F transcription factor 2 |
1871 | E2F3; E2F transcription factor 3 |
|
Variant |
1029v1 (CDKN2A*) CDKN2A deletion
|
Reference |
|
Authors |
Schmid RM. |
Title |
Genetic basis of pancreatic cancer. |
Journal |
|
Reference |
|
Authors |
Bansal K, Liang ML, Rutka JT. |
Title |
Molecular biology of human gliomas. |
Journal |
|
Reference |
|
Authors |
Miller AJ, Mihm MC Jr. |
Title |
Melanoma. |
Journal |
|
Reference |
|
Authors |
Wolff EM, Liang G, Jones PA. |
Title |
Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer. |
Journal |
|
Reference |
|
Authors |
Lee JS |
Title |
The mutational landscape of hepatocellular carcinoma. |
Journal |
|
Reference |
|
Authors |
Kudo M |
Title |
Signaling pathway and molecular-targeted therapy for hepatocellular carcinoma. |
Journal |
|
LinkDB |
|